4.810USD-0.62%Mkt Cap: 112.83M USDP/E: —Last update: 2026-05-22
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on thera…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap112.83M USD
Enterprise Value62.81M USD
Revenue (TTM)7.94M USD
Gross Profit-8.80M USD
Net Income (TTM)-21.23M USD
Revenue/Share0.4360 USD
Last Price4.810 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.19
PEG—
EV/EBITDA-3.11
EV/Revenue7.91
P/S14.30
P/B2.32
EPS (TTM)-1.15
EPS (Forward)-1.16
52W Range
3.71027% of range7.750
52W High7.750 USD
52W Low3.710 USD
Profitability
Gross Margin-110.79%
Oper. Margin-3038.15%
EBITDA Margin-254.38%
Profit Margin-267.14%
ROE-49.33%
ROA-42.49%
Growth
Revenue Growth-2.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.74M USD
CapEx (TTM)—
FCF Margin-136.83%
FCF Yield-9.63%
Net Debt-50.72M USD
Net Debt/EBITDA2.51
Balance Sheet
Debt/Equity—
Current Ratio15.02
Quick Ratio14.30
Book Value/Sh2.088 USD
Cash/Share2.162 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)15.64 USD
Target Range14.00 USD – 18.00 USD
# Analysts7
Ownership
Shares Out.23.46M
Float17.83M
Insiders14.69%
Institutions35.37%
Short Interest
Short Ratio5.6d
Short % Float3.70%
Short % Out.3.52%
Shares Short825.57K
Short (prev mo.)882.76K
Technical
SMA 504.363 (+10.3%)
SMA 2005.349 (-10.1%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)163.71K
Avg Vol (10d)219.67K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—